Accurate Investment Solutions’s Blueprint Medicines BPMC Stock Holding History

Accurate Investment Solutions’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$6K	–	51
2020 Q1	$6K	Hold	100	–	–	﹤0.01%	328
2019 Q4	$8K	Hold	100	–	–	0.01%	308
2019 Q3	$7K	Hold	100	–	–	0.01%	252
2019 Q2	$9K	Hold	100	–	–	0.01%	237
2019 Q1	$8K	Hold	100	–	–	0.01%	226
2018 Q4	$5K	Hold	100	–	–	﹤0.01%	228
2018 Q3	$8K	Hold	100	–	–	0.01%	238
2018 Q2	$6K	Hold	100	–	–	﹤0.01%	317
2018 Q1	$9K	Hold	100	–	–	0.01%	262
2017 Q4	$8K	Hold	100	–	–	0.01%	265
2017 Q3	$7K	Hold	100	–	–	0.01%	279
2017 Q2	$5K	Hold	100	–	–	﹤0.01%	247
2017 Q1	$4K	Hold	100	–	–	﹤0.01%	235
2016 Q4	$3K	Hold	100	–	–	﹤0.01%	241
2016 Q3	$3K	Hold	100	–	–	﹤0.01%	230
2016 Q2	$2K	Buy	+100	New	+$1.82K	﹤0.01%	248

Other funds holding BPMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Accurate Investment Solutions's BPMC Position: Q2 2020 in Review

Accurate Investment Solutions sold out of Blueprint Medicines (BPMC) in Q2 2020, closing a stake of 100 shares — an estimated $6K sold.

Accurate Investment Solutions first reported a position in BPMC in Q2 2016 and held it in 16 quarters. The position peaked at $9K in Q2 2019. 234 funds tracked by Wall St. Rank hold BPMC as of Q2 2020.

Accurate Investment Solutions reported no remaining Blueprint Medicines position as of Q2 2020 after selling out during the quarter.
Accurate Investment Solutions sold 100 Blueprint Medicines shares in Q2 2020, an estimated $6K.
Accurate Investment Solutions first reported a position in Blueprint Medicines in Q2 2016 and held it in 16 quarters.
Accurate Investment Solutions's Blueprint Medicines position peaked at $9K in Q2 2019.
234 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.